Karolinska Development-backed regenerative implant producer OssDsign has booked $15.8m after selling out the original issue for its forthcoming listing, and is now looking to generate up to $2.4m from the overallotment.
OssDsign, a Sweden-based regenerative implant producer backed by Karolinska Development, the investment arm of Karolinska Institute, is looking to raise an additional Skr22.7m ($2.4m) from its listing on the Nasdaq First North exchange after raising $15.8m from the original allotment.
The initial issue was approximately 117% oversubscribed, with each share selling for $2.87. Roughly 74% of the allotment was sold to institutional investors including Alto Invest, Handelsbanken Fonder, Lancelot Asset Management and Consensus Asset Management, along with private investors…
